The objective of this study is to test the idea that Pulsed Electromagnetic Field (PEMF) therapy will serve as a safe therapeutic modality that can effectively be administered simultaneously with bladder instillations of a bupivacaine-heparin cocktail to improve the chronic pain and/or associated symptoms of Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) patients. The study team will distribute the PEMF device to female adults with IC/BPS who have been prescribed bladder instillations of bupivacaine-heparin to see if PEMF therapy in conjunction with bladder instillations of heparin and bupivacaine may be more effective in reducing pain levels and symptomatology of IC/BPS than instillations alone.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Pelvic pain scores as measured by the Brief Pain Inventory (BPI) Short Form - Baseline
Timeframe: Baseline
Pelvic pain scores as measured by the Brief Pain Inventory (BPI) Short Form - Week 3
Timeframe: Week 3
Pelvic pain scores as measured by the Brief Pain Inventory (BPI) Short Form - Week 6
Timeframe: Week 6